CN Patent

CN1960746A — 稳定性提高的含生物分子配方

Assigned to Intarcia Therapeutics Inc · Expires 2007-05-09 · 19y expired

What this patent protects

一种供治疗用途的悬浮液配方包括一种显示粘性流体特征的非水疏水性载剂、一种包含分散于该载剂中的生物分子的干微粒配方、和一种掺入该载剂和干微粒配方中至少一种中的表面活性剂。一种干微粒配方包括一种干扰素、一种缓冲剂、一种表面活性剂、和一种或多种选自下列组成的一组稳定剂：碳水化合物、抗氧剂、和氨基酸。

USPTO Abstract

一种供治疗用途的悬浮液配方包括一种显示粘性流体特征的非水疏水性载剂、一种包含分散于该载剂中的生物分子的干微粒配方、和一种掺入该载剂和干微粒配方中至少一种中的表面活性剂。一种干微粒配方包括一种干扰素、一种缓冲剂、一种表面活性剂、和一种或多种选自下列组成的一组稳定剂：碳水化合物、抗氧剂、和氨基酸。

Drugs covered by this patent

Patent Metadata

Patent number
CN1960746A
Jurisdiction
CN
Classification
—
Expires
2007-05-09
Drug substance claim
No
Drug product claim
No
Assignee
Intarcia Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.